Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Depression and health related quality of life in non-cirrhotic chronic hepatitis B patients and hepatitis B carriers.

Altindag A, Cadirci D, Sirmatel F.

Neurosciences (Riyadh). 2009 Jan;14(1):56-9.

PMID:
21048575
2.

Psychiatric morbidity and its effect on the quality of life of patients with chronic hepatitis B and hepatitis C.

Ozkan M, Corapçioglu A, Balcioglu I, Ertekin E, Khan S, Ozdemir S, Karayün D, Unsalver BO, Kocaman N, Kaymakglu S, Köroglu G.

Int J Psychiatry Med. 2006;36(3):283-97.

PMID:
17236696
3.

[The relationship between emotional distress, cognitive performance and health - related quality of life in patients with hepatitis C prior to antiviral treatment].

Rothenhäusler HB, Scherr M, Putz-Bankuti C, Kapper A, Stepan A, Baranyi A, Haas-Krammer A, Haas B, Stauber R.

Fortschr Neurol Psychiatr. 2009 Aug;77(8):457-63. doi: 10.1055/s-0028-1109574. Epub 2009 Aug 12. German.

PMID:
19676008
4.
5.

Relationship between depression and health-related quality of life in older Korean patients with chronic obstructive pulmonary disease.

Kil SY, Oh WO, Koo BJ, Suk MH.

J Clin Nurs. 2010 May;19(9-10):1307-14. doi: 10.1111/j.1365-2702.2009.03053.x.

PMID:
20500340
6.

Determination of serum hepatitis B virus DNA in chronic HBsAg carriers: clinical significance and correlation with serological markers.

Yalçin K, Değertekin H, Alp MN, Tekeş S, Satici O, Budak T.

Turk J Gastroenterol. 2003 Sep;14(3):157-63.

7.

[Influence of depression on the quality of life in patients with chronic hepatitis C].

Pavić S, Švirtlih N, Simonović J, Delić D.

Srp Arh Celok Lek. 2011 Sep-Oct;139(9-10):645-50. Serbian.

8.

Reduced quality of life in patients with chronic viral liver disease as assessed by SF12 questionnaire.

Svirtlih N, Pavic S, Terzic D, Delic D, Simonovic J, Gvozdenovic E, Boricic I.

J Gastrointestin Liver Dis. 2008 Dec;17(4):405-9.

9.

Physical and psychosocial contributors to quality of life in veterans with hepatitis C not on antiviral therapy.

Rowan PJ, Al-Jurdi R, Tavakoli-Tabasi S, Kunik ME, Satrom SL, El-Serag HB.

J Clin Gastroenterol. 2005 Sep;39(8):731-6.

PMID:
16082286
10.

Antibody response following hepatitis B vaccination in dialysis patients: does depression and life quality matter?

Afsar B, Elsurer R, Eyileten T, Yilmaz MI, Caglar K.

Vaccine. 2009 Sep 25;27(42):5865-9. doi: 10.1016/j.vaccine.2009.07.055. Epub 2009 Aug 3.

PMID:
19654067
11.

Relationship between levels of DNA damage in lymphocytes and histopathological severity of chronic hepatitis C and various clinical forms of hepatitis B.

Bolukbas C, Bolukbas FF, Kocyigit A, Aslan M, Selek S, Bitiren M, Ulukanligil M.

J Gastroenterol Hepatol. 2006 Mar;21(3):610-6.

PMID:
16638108
12.

The effect of hepatitis C virus infection on health-related quality of life in prisoners.

Thein HH, Butler T, Krahn M, Rawlinson W, Levy MH, Kaldor JM, Dore GJ.

J Urban Health. 2006 Mar;83(2):275-88.

13.

Sexual dysfunction is highly prevalent among men with chronic hepatitis C virus infection and negatively impacts health-related quality of life.

Danoff A, Khan O, Wan DW, Hurst L, Cohen D, Tenner CT, Bini EJ.

Am J Gastroenterol. 2006 Jun;101(6):1235-43.

PMID:
16771944
14.

Quality of life and related factors among chronic hepatitis B-infected patients: a multi-center study, Turkey.

Karacaer Z, Cakir B, Erdem H, Ugurlu K, Durmus G, Ince NK, Ozturk C, Hasbun R, Batirel A, Yilmaz EM, Bozkurt I, Sunbul M, Aynioglu A, Atilla A, Erbay A, Inci A, Kader C, Tigen ET, Karaahmetoglu G, Coskuner SA, Dik E, Tarakci H, Tosun S, Korkmaz F, Kolgelier S, Karadag FY, Erol S, Turker K, Necan C, Sahin AM, Ergen P, Iskender G, Korkmaz P, Eroglu EG, Durdu Y, Ulug M, Deniz SS, Koc F, Alpat SN, Oztoprak N, Evirgen O, Sozen H, Dogan M, Kaya S, Kaya S, Altindis M, Aslan E, Tekin R, Sezer BE, Ozdemir K, Ersoz G, Sahin A, Celik I, Aydin E, Bastug A, Harman R, Ozkaya HD, Parlak E, Yavuz I, Sacar S, Comoglu S, Yenilmez E, Sirmatel F, Balkan II, Alpay Y, Hatipoglu M, Denk A, Senol G, Bitirgen M, Geyik MF, Guner R, Kadanali A, Karakas A, Namiduru M, Udurgucu H, Boluktas RP, Karagoz E, Ormeci N.

Health Qual Life Outcomes. 2016 Nov 3;14(1):153.

15.

Anti-hepatitis delta virus seroprevalence and risk factors in patients with hepatitis B in Southeast Turkey.

Celen MK, Ayaz C, Hosoglu S, Geyik MF, Ulug M.

Saudi Med J. 2006 May;27(5):617-20.

PMID:
16680248
16.

Health-related quality of life in methadone maintenance patients with untreated hepatitis C virus infection.

Batki SL, Canfield KM, Smyth E, Ploutz-Snyder R.

Drug Alcohol Depend. 2009 May 1;101(3):176-82. doi: 10.1016/j.drugalcdep.2008.12.012. Epub 2009 Feb 23.

PMID:
19233573
17.

[Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].

Sayan M, Mutlu B, Erdoğan S, Meriç M, Willke A.

Mikrobiyol Bul. 2007 Jan;41(1):87-93. Turkish.

PMID:
17427556
18.

Serum hepatitis B surface antigen levels in the natural history of chronic hepatitis B infection.

Jang JW, Yoo SH, Kwon JH, You CR, Lee S, Lee JH, Chung KW.

Aliment Pharmacol Ther. 2011 Dec;34(11-12):1337-46. doi: 10.1111/j.1365-2036.2011.04888.x. Epub 2011 Oct 19.

19.

Hepatitis B virus genotype D prevails in patients with persistently elevated or normal ALT levels in Turkey.

Yalcin K, Degertekin H, Bahcecioglu IH, Demir A, Aladag M, Yildirim B, Horasanli S, Ciftci S, Badur S.

Infection. 2004 Feb;32(1):24-9.

PMID:
15007739
20.

Transmission of hepatitis B and hepatitis delta viruses in the households of chronic hepatitis B surface antigen carriers: a regression analysis of indicators of risk.

Craxì A, Tinè F, Vinci M, Almasio P, Cammà C, Garofalo G, Pagliaro L.

Am J Epidemiol. 1991 Sep 15;134(6):641-50.

PMID:
1951268

Supplemental Content

Support Center